Is DVA a good stock to buy? We came across a bullish thesis on DaVita Inc. on StockCompass’s Substack. In this article, we will summarize the bulls’ thesis on DVA. DaVita Inc.'s share was trading at $228.03 as of July 1st. DVA’s trailing and forward P/E were 21.43 and 15.34 respectively according to Yahoo Finance.
[caption id="attachment_567108" align="aligncenter" width="750"]DaVita Inc. is one of the largest dialysis providers in the United States, serving patients with end-stage renal disease through a business model built on recurring,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.